Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues-Reference-Cited by-全球学者库

Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues

Published:2022-03-17 Issue:6 Volume:29 Page:420-431
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Wang Yang¹²,Liao Hao³⁴,Deng Zhongping⁵⁶,Liu Yanna³,Bian Dandan¹²,Ren Yan¹²,Yu Guangxin³,Jiang Yingying¹²^ORCID,Bai Li¹²,Liu Shuang¹²,Liu Mei¹²,Zhou Li¹²,Chen Yu¹²,Duan Zhongping¹²,Lu Fengmin³^ORCID,Zheng Sujun¹²^ORCID

Affiliation:

1. Liver Disease Center Beijing YouAn Hospital Capital Medical University Beijing China

2. Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment & Research Beijing YouAn Hospital Capital Medical University Beijing China

3. Department of Microbiology and Infectious Disease Center School of Basic Medical Sciences Peking University Health Science Center Beijing China

4. Intervention and Cell Therapy Center Peking University Shenzhen Hospital Shenzhen Peking University‐The Hong Kong University of Science and Technology Medical Center Shenzhen China

5. Academy for Advanced Interdisciplinary Studies Peking University Beijing China

6. Hunan Provincial Key Laboratory of Gene Diagnostic Technology Changsha China

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13671

Reference27 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

2. Potential use of serum HBV RNA in antiviral therapy for chronic hepatitis B in the era of nucleos(t)ide analogs

3. Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy

4. Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”

5. Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive, nucleoside-naive patients treated with entecavir

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective detection of HBV pre-genomic RNA in chronic hepatitis B patients using a novel RT-PCR assay;Clinical and Experimental Medicine;2023-08-12

2. Effects of Entecavir on Serum Hepatitis B Virus-DNA, Interferon-γ, and Pregenomic RNA in Patients with Chronic Hepatitis B Virus Infection;Hepatitis Monthly;2023-02-20

3. Serum HBV RNA is associated with liver fibrosis regression in HBeAg ‐positive chronic hepatitis B patients treated with nucleos(t)ide analogues;Journal of Viral Hepatitis;2023-01-10

4. Levels of HBV RNA in chronic HBV infected patients during first-line nucleos(t)ide analogues therapy;Infectious Agents and Cancer;2022-12-07